Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version)
Mil. med. res. (Lond.); 7 (41), 2020
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness,
coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis
and treatment guidelines for clinicians caring for patients are needed. In the ...
Chemoprevention/methods, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Pandemics/prevention & control, Betacoronavirus/drug effects, Evidence-Based Practice/methods, Anti-Retroviral Agents/therapeutic use, Lopinavir/therapeutic use, Chloroquine/therapeutic use, Receptors, Interleukin-6/therapeutic use, Hydroxychloroquine/therapeutic use, Plasma/immunology